ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...
This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...
As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential ...
Trump said on Saturday the directive would “dramatically accelerate” access to research and potential treatments.
VO2 max is a measure of the maximum amount of oxygen the body can handle during intense exercise. A doctor explains how it's ...
One of the latest clock-reversing experiments causing a buzz is a technique called therapeutic plasma exchange, a procedure ...
Texas is leading the charge to turn an African psychedelic into a life-saving drug. But will iboga’s historic stewards get a ...
The world of peptides has exploded in wellness circles, but the benefits of injecting these gray-market molecules rest on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results